• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation.

作者信息

Langrehr J M, Klupp J, Pfitzmann R, Neumann U, Lohmann R, Jonas S, Neuhaus R, Steinmüller T, Neuhaus P

机构信息

Department of Surgery, Charité Campus Virchow-Klinikum, Humboldt-University Berlin, Berlin, Germany.

出版信息

Transplant Proc. 2001 Feb-Mar;33(1-2):1520. doi: 10.1016/s0041-1345(00)02579-3.

DOI:10.1016/s0041-1345(00)02579-3
PMID:11267404
Abstract
摘要

相似文献

1
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation.肝移植后基于他克莫司的四联与双联诱导治疗的前瞻性随机试验。
Transplant Proc. 2001 Feb-Mar;33(1-2):1520. doi: 10.1016/s0041-1345(00)02579-3.
2
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial.
Transplantation. 2000 Jun 15;69(11):2343-53. doi: 10.1097/00007890-200006150-00022.
3
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
Transplant Proc. 2001 May;33(3):2330-1. doi: 10.1016/s0041-1345(01)02011-5.
4
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.肝移植后抗体诱导治疗联合他克莫司免疫抑制的风险与获益
Transplant Proc. 1998 Jun;30(4):1443-4. doi: 10.1016/s0041-1345(98)00308-x.
5
FK506 for primary and rescue therapy following liver transplantation.
Transplant Proc. 1998 Jun;30(4):1409-10. doi: 10.1016/s0041-1345(98)00293-0.
6
Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.肝移植后基于他克莫司的四联疗法的前瞻性评估。
Transplant Proc. 2002 Feb;34(1):108. doi: 10.1016/s0041-1345(01)02691-4.
7
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Transplant Proc. 1993 Aug;25(4):2693-4.
8
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.在使用白细胞介素-2受体抗体BT563进行诱导治疗的情况下，原位肝移植后的慢性排斥反应会增加。
Transplant Proc. 2001 May;33(3):2290-1. doi: 10.1016/s0041-1345(01)01993-5.
9
Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation.
Transplant Proc. 2000 Dec;32(8):2817-9. doi: 10.1016/s0041-1345(00)01895-9.
10
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation.肝移植后采用包括抗胸腺细胞球蛋白或白细胞介素-2受体抗体或基于FK 506的诱导治疗的四联诱导疗法。
Transplant Proc. 1999 Feb-Mar;31(1-2):380. doi: 10.1016/s0041-1345(98)01670-4.

引用本文的文献

1
Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.成人肝移植受者的诱导免疫抑制：一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013203. doi: 10.1002/14651858.CD013203.pub2.
2
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.肝移植成年受者的维持性免疫抑制：一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD011639. doi: 10.1002/14651858.CD011639.pub2.
3
Antibody induction versus corticosteroid induction for liver transplant recipients.
肝移植受者的抗体诱导与皮质类固醇诱导
Cochrane Database Syst Rev. 2014 May 31;2014(5):CD010252. doi: 10.1002/14651858.CD010252.pub2.
4
Tacrolimus: a further update of its use in the management of organ transplantation.他克莫司：其在器官移植管理中应用的进一步更新
Drugs. 2003;63(12):1247-97. doi: 10.2165/00003495-200363120-00006.